~~<i id='0FC77A6D80'><strike id='0FC77A6D80'><tt id='0FC77A6D80'><pre id='0FC77A6D80'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：Wikipedia 2025-09-01 15:20:22 - browse：7647

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

“We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： How redistricting in 6 states could affect who controls Congress

focus

entertainment

Wikipedia

hotspot

2:36Anemptyconferenceroomisseeninthisundatedstockphoto.Pgiam/STOCKPHOTO/GettyImagesYearsafterthedeat

WSS

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

White House drug shortages task force keeps mum with Congress

Neutralizing antibodies against HIV shows promise in children

What to know about a major upcoming Wegovy heart health study

The PBM ad wars are taking over Washington, D.C.

Genentech weighs delaying cancer therapy after drug pricing law

explore

fashion

focus

Peter Hotez and the public health issue of online harassment

FDA approves Leqembi, a milestone in Alzheimer’s treatment

ChatGPT in medicine: STAT answers readers' burning questions

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

In age of alternative facts, a scholarly course on calling out crap

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

What does generative AI mean for health care? We asked experts

Novo acquires Inversago for up to $1 billion

Heart attack and stroke risk calculators need revising

Who are the detained American citizens released from prison in Iran?

focus

Large hospital system sues Multiplan for low

Neutralizing antibodies against HIV shows promise in children

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Covid's long

Who are the detained American citizens released from prison in Iran?

What to know about a major upcoming Wegovy heart health study

focus

entertainment

Wikipedia

hotspot